Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+27.79%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$7.1B
AUM Growth
+$4.71B
(+197%)
Cap. Flow
+$3.99B
Cap. Flow
% of AUM
56.24%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
1,020
New
424
Increased
501
Reduced
44
Closed
50
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$577M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$492M |
| 3 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
$178M |
| 4 |
Microsoft
MSFT
|
$139M |
| 5 |
Apple
AAPL
|
$132M |
Top Sells
| 1 |
VanEck Junior Gold Miners ETF
GDXJ
|
$312M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$136M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
$31.7M |
| 4 |
Idexx Laboratories
IDXX
|
$4.16M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$3.61M |
Sector Composition
| 1 | Technology | 24.57% |
| 2 | Financials | 13.35% |
| 3 | Energy | 3.93% |
| 4 | Healthcare | 3.4% |
| 5 | Real Estate | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Invesco
IVZ
$9.81B
| $1.16M | 0.02% |
107,388
+92,286
| +611% | +$993K |
|
|
COR
502
DELISTED
Coresite Realty Corporation
COR
| $1.15M | 0.02% |
+9,493
| New | +$1.15M |
|
503
Associated Banc-Corp
ASB
$4.42B
| $1.15M | 0.02% |
+83,742
| New | +$1.15M |
|
504
Rexford Industrial Realty
REXR
$10.2B
| $1.14M | 0.02% |
+27,580
| New | +$1.14M |
|
|
ACC
505
DELISTED
American Campus Communities, Inc.
ACC
| $1.14M | 0.02% |
+32,628
| New | +$1.14M |
|
506
Builders FirstSource
BLDR
$16.5B
| $1.13M | 0.02% |
+54,796
| New | +$1.13M |
|
507
Alkermes
ALKS
$4.94B
| $1.13M | 0.02% |
58,383
+41,444
| +245% | +$804K |
|
508
Boston Scientific
BSX
$159B
| $1.13M | 0.02% |
32,102
+21,377
| +199% | +$750K |
|
509
Esperion Therapeutics
ESPR
$540M
| $1.13M | 0.02% |
+21,960
| New | +$1.13M |
|
510
Halozyme
HALO
$8.76B
| $1.12M | 0.02% |
+41,845
| New | +$1.12M |
|
511
CrowdStrike
CRWD
$105B
| $1.11M | 0.02% |
+11,077
| New | +$1.11M |
|
512
Inseego
INSG
$199M
| $1.11M | 0.02% |
+9,571
| New | +$1.11M |
|
513
SL Green Realty
SLG
$4.4B
| $1.11M | 0.02% |
23,228
+15,723
| +210% | +$750K |
|
|
JNPR
514
DELISTED
Juniper Networks
JNPR
| $1.1M | 0.02% |
48,253
+36,236
| +302% | +$828K |
|
515
Ultragenyx Pharmaceutical
RARE
$3.07B
| $1.1M | 0.02% |
14,033
+7,335
| +110% | +$574K |
|
516
Reinsurance Group of America
RGA
$12.8B
| $1.1M | 0.02% |
+13,983
| New | +$1.1M |
|
|
SAGE
517
DELISTED
Sage Therapeutics
SAGE
| $1.1M | 0.02% |
+26,379
| New | +$1.1M |
|
|
IMMU
518
DELISTED
Immunomedics Inc
IMMU
| $1.09M | 0.02% |
30,876
+10,933
| +55% | +$387K |
|
519
BridgeBio Pharma
BBIO
$10.2B
| $1.09M | 0.02% |
+33,309
| New | +$1.09M |
|
520
Agios Pharmaceuticals
AGIO
$2.09B
| $1.08M | 0.02% |
20,257
+13,251
| +189% | +$708K |
|
521
Karyopharm Therapeutics
KPTI
$57.2M
| $1.08M | 0.02% |
3,812
+2,984
| +360% | +$848K |
|
522
TG Therapeutics
TGTX
$5.11B
| $1.08M | 0.02% |
55,557
+44,830
| +418% | +$873K |
|
523
First American
FAF
$6.83B
| $1.07M | 0.02% |
+22,328
| New | +$1.07M |
|
|
BPMC
524
DELISTED
Blueprint Medicines
BPMC
| $1.07M | 0.02% |
13,664
+8,309
| +155% | +$648K |
|
525
Fate Therapeutics
FATE
$116M
| $1.07M | 0.02% |
+31,065
| New | +$1.07M |
|